Orforglipron
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Orforglipron?
The generic name for Foundayo, and the first non-peptide GLP-1 agonist to reach approval.
Its contraceptive interaction works differently from tirzepatide's — co-localization in the GI tract rather than delayed gastric emptying — so the two warnings are not interchangeable.
What is orforglipron / Foundayo →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Orforglipron comes up on this site
On GLP Watchdog, Orforglipron comes up in 6 research articles, 15 seller reviews and 2 tools.
Research that discusses it
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- What is orforglipron / Foundayo
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers